(Q28254167)

English

Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies

scientific article

In more languages

Statements

scholarly article

0 references

Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies (English)

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

ChEBI release 2020-05-28

author name string

Mona Darwish

1

0 references

Mary Kirby

2

0 references

Edward T Hellriegel

3

0 references

Philmore Robertson

4

0 references

language of work or name

0 references

publication date

2009

0 references

Clinical Drug Investigation

0 references

29

0 references

613-23

0 references

9

0 references

Clinical pharmacokinetic profile of modafinil

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of steady-state plasma concentrations of armodafinil and modafinil late in the day following morning administration: post hoc analysis of two randomized, double-blind, placebo-controlled, multiple-dose studies in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing Regimen Effects of Modafinil for Improving Daytime Wakefulness in Patients With Narcolepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663523

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11315280-000000000-00000

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254167&oldid=1987822055"